Novum Orthopedic Partners Expands Its Physician Practice Management Platform in Dallas-Fort Worth with Investment in North Texas Orthopedics & Spine Center

Novum Orthopedic Partners, a leader in orthopedics and spine practice management, has made a strategic investment in Dallas-Fort Worth-based North Texas Orthopedics & Spine Center (NTO), one of the regions most respected orthopedic practices.

NTO delivers a full suite of musculoskeletal services, including orthopedic consultation, surgeries, pain management, diagnostic imaging, and physical therapy through an integrated care network.

“Novum’s footprint in the Dallas-Fort Worth region is rapidly growing, and we see an opportunity to operationalize our practice in a way that delivers more value to our patients, physicians, and leadership team,” said Lora Fulmer, Chief Executive Officer at NTO. “By joining Novum, we expect to streamline burdensome administrative tasks for our staff, especially in areas such as billing and compliance, while providing our physicians with real-time operational and clinical benchmarks to improve patient outcomes and overall practice performance.”

“Novum’s ability to deliver value to practice providers and improve the patient experience are just two reasons we joined the Novum team,” added Dr. Michael Briseño, President and Spine Surgeon at NTO. “Our physician group is excited to enter into this new era of medicine while partnering with Novum and their growing bench of outstanding orthopedic providers and support networks.”

The investments are a continuum of Novum’s strategy to partner with like-minded, entrepreneurial orthopedic practices across the U.S. The model provides practice partners with a full suite of technology-enabled compliance, revenue cycle and financial services that can improve operational efficiency and empower physicians to deliver best-in-class clinical care. With the closing of NTO, Novum has expanded its practice management platform to include 47 orthopedic and spine physician partners and more than 400 employees across 10 practice locations, 3 affiliated surgical facilities and 10 physical therapy sites in Texas.

“We’ve developed an attractive, fast-growing model centered around delivering technology-enabled infrastructure and outstanding personnel,” said Eric Slimmer, Novum Orthopedic Partners Chief Development Officer. “The model empowers independent orthopedic practices to remain locally managed and physician-led while equipping them with data-driven solutions that create a better experience for patients and physicians.”

“We are excited to welcome the NTO team to the Novum partnership,” said Alex Sacripanti, Vice President at AMCP. “NTO’s commitment to best-in-class clinical quality, together with Novum’s access to resources and our capital investment, creates a powerful partnership to grow and expand Novum in the highly attractive Texas market. We are thrilled to partner with their team of providers.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”